Recent Post
Australian MedTech industry setting global benchmark for collaboration during COVID-19
VIVA! Communications’ Principal, Kirsten Bruce caught up with CEO of the Medical Technology Association of Australia (MTAA), Ian Burgess, in Sydney this week to discuss the pivotal role played by the MedTech industry throughout the COVID-19 pandemic, the various challenges encountered, and key learnings poised to shape the industry’s future. Watch the interview below. Over…
Read MoreImproving clinical standards for the screening, diagnosis & management of osteoporosis across APAC
The Asia Pacific Consortium on Osteoporosis (APCO), comprising 39 clinical experts from 19 countries and regions across Asia Pacific (APAC), and its proposed ‘Framework’ aims to drive, and facilitate benchmarking for the provision of quality osteoporosis care across the region. According to a co-authored APCO member and Chair viewpoint article published on Monday, June 22,…
Read MoreNew report reveals the impact of MedTech collaborations on COVID
A series of reports released today by MTPConnect, an independent, industry-led organisation, highlight the key role the MedTech sector played in the COVID-19 pandemic response. The reports, welcomed by the Medical Technology Association of Australia (MTAA), reveal how the MedTech, biotechnology and pharmaceutical sector was impacted by COVID-19 at local and multinational levels, as well…
Read MoreNew combination therapy now reimbursed for Aussies living with incurable blood cancer
Yesterday, VIVA! partnered with Celgene, a Bristol-Myers Squibb company and Myeloma Australia to announce the listing of REVLIMID® (lenalidomide) in combination with bortezomib (Velcade) and dexamethasone (RVd) on the Pharmaceutical Benefits Scheme (PBS). Australians living with the incurable blood cancer, multiple myeloma now have access to this new treatment option. The three drug regimen will…
Read MoreInfectious diseases expert issues public health warning to avoid secondary surge in COVID-19
This week, VIVA! Communications’ Principal and owner, Kirsten Bruce, Sydney spoke with internationally renowned Infectious Diseases Paediatrician and Immunisation expert, Professor Robert Booy, Sydney. They discussed the impact of COVID-19 on Australians to date, its potential implications moving forward, and the barriers facing scientists in their race to develop a vaccine. The rapid and effective…
Read More